News & Updates

Treatment with the combination of statin and ezetimibe to achieve a low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL works well to consistently reduce the risk of subsequent stroke, according to a post hoc analysis of the Treat Stroke to Target (TST) trial.

New drug applications approved by US FDA as of 16-30 Sep 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Remotely supervised transcranial direct current stimulation (tDCS) helps improve cognitive function in stroke survivors, especially those with moderate cognitive decline, according to a study from Korea.

Distress levels are high among patients with high-grade gliomas (HGG) and demonstrate high unmet need for distress screening and referral services, a new study has found.

A soft, miniaturized bioresorbable implant that delivers focused, minimally invasive cooling power in living tissues can help alleviate pain on demand without the use of medications and may provide an alternative to opioids and other highly addictive painkillers.